Inspire Medical Systems (INSP) Stock Forecast, Price & News

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last twelve months. There are currently 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" INSP shares.
View INSP analyst ratings or view top-rated stocks.

11 Wall Street research analysts have issued 12-month price objectives for Inspire Medical Systems' shares. Their INSP share price forecasts range from $308.00 to $380.00. On average, they anticipate the company's stock price to reach $345.08 in the next year. This suggests a possible upside of 77.2% from the stock's current price.
View analysts price targets for INSP or view top-rated stocks among Wall Street analysts.

Inspire Medical Systems' stock was trading at $251.88 on January 1st, 2023. Since then, INSP shares have decreased by 22.7% and is now trading at $194.7750.
View the best growth stocks for 2023 here.

Inspire Medical Systems saw a increase in short interest in September. As of September 15th, there was short interest totaling 1,180,000 shares, an increase of 14.6% from the August 31st total of 1,030,000 shares. Based on an average daily volume of 512,100 shares, the short-interest ratio is currently 2.3 days.
View Inspire Medical Systems' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 7th 2023.
View our INSP earnings forecast.

Inspire Medical Systems, Inc. (NYSE:INSP) issued its quarterly earnings data on Tuesday, August, 1st. The company reported ($0.41) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.51) by $0.10. The company earned $151.09 million during the quarter, compared to the consensus estimate of $136.47 million. Inspire Medical Systems had a negative trailing twelve-month return on equity of 8.21% and a negative net margin of 7.81%. The business's quarterly revenue was up 65.3% on a year-over-year basis. During the same quarter last year, the company earned ($0.53) EPS.

ETFs with the largest weight of Inspire Medical Systems (NYSE:INSP) stock in their portfolio include Harbor Health Care ETF (MEDI), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Fidelity Digital Health ETF (FDHT), Invesco Dorsey Wright Healthcare Momentum ETF (PTH), BNY Mellon Innovators ETF (BKIV), Principal Healthcare Innovators ETF (BTEC), Franklin Intelligent Machines ETF (IQM) and WisdomTree U.S. Growth & Momentum Fund (WGRO).

Inspire Medical Systems issued an update on its FY 2023 earnings guidance on Tuesday, August, 1st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $600.00 million-$610.00 million, compared to the consensus revenue estimate of $589.63 million.

2 employees have rated Inspire Medical Systems Chief Executive Officer Tim Herbert on Glassdoor.com. Tim Herbert has an approval rating of 100% among the company's employees. This puts Tim Herbert in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Inspire Medical Systems investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Cisco Systems (CSCO), Bank of America (BAC), DocuSign (DOCU), Pfizer (PFE), Block (SQ), Zynga (ZNGA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ).

(INSP) raised $75 million in an initial public offering on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.

Inspire Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "INSP."

Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of INSP stock can currently be purchased for approximately $194.78.

Inspire Medical Systems (NYSE:INSP) has a market capitalization of $5.71 billion and generates $407.86 million in revenue each year. The company earns $-44,880,000.00 in net income (profit) each year or ($1.44) on an earnings per share basis.

The company employs 755 workers across the globe.

Inspire Medical Systems' mailing address is 5500 WAYZATA BLVD SUITE 1600, GOLDEN VALLEY MN, 55416. The official website for the company is www.inspiresleep.com. The company can be reached via phone at (844) 672-4357 or via email at inspire@lifesciadvisors.com.